Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic
Baltimore opted out of a national settlement last year, instead pursuing its own claim against the opioid manufacturer.
Drug Manufacturers
Combating Pharmaceutical Crime with On-Dose Authentication
Are PBMs to blame for high drug prices in the US?
Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn
AstraZeneca may pull plug on UK vaccine manufacturing plans
Chime looks to expand manufacturing capacity and establish European presence
Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval
Drug development costs predicted to soar as BIOSECURE Act gains momentum
